Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest antiviral therapy Stories

2014-01-29 16:28:29

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fmzb68/antiviral) has announced the addition of a new report "Antiviral Therapeutics - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/fmzb68/antiviral ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report reviews the current state-of-art of antiviral approaches including vaccines,...

2013-12-12 11:06:49

Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected...

2013-07-10 16:26:17

DUBLIN, July 10, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bmljl6/antiviral) has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/bmljl6/antiviral ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report reviews the current state-of-art of antiviral approaches...

2011-05-03 14:48:15

A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists. University of Manchester researchers, working with colleagues in Canada, have discovered how the antiviral drug lopinavir attacks HPV by switching on a natural viral defence system in infected cells. The study, published in the journal Antiviral Therapy, builds on the team's previous work in 2006 that first identified lopinavir as a potential therapeutic...

2011-02-24 18:56:24

High costs, insurance status, and eligibility issues restrict treatment options New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans have access to antiviral therapy; the remaining are either uninsured or not candidates for therapy due to treatment contraindications. Details of this study are published...

2010-10-30 07:10:00

BOSTON, Oct. 30 /PRNewswire/ -- Researchers from the University of Bari, Italy, concluded that treating patients after transplantation with antiviral therapy creates a sustained viral response (SVR) and protects them from liver-related deaths. The purpose of this study was to determine the long-term clinical outcomes of patients posttransplant who underwent antiviral therapy for recurrent hepatitis C virus (HCV) infection of the liver graft. The use in clinical practice of antiviral...

2010-09-14 12:40:17

Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals. "Herpes simplex virus (HSV) is a common cause of corneal disease and is the leading infectious cause of corneal blindness among developed nations," the authors write as background information in the article....

2010-06-24 16:26:10

Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). But now, researchers from the Division of Gastroenterology and Hepatology at Thomas Jefferson University are reporting that the antiviral therapy also prevents recurrence of HCC and extends patients' lives. The standard of care for patients with HCC is local ablation of the tumor, unless it is large or has metastasized. However, HCC tumors...

2010-05-27 16:14:25

Treatment benefits patients with advanced liver disease from HCV Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C (HCV) infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases...

2009-11-24 16:23:42

Research suggests lack of diagnosis is primary barrier to treatment Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007. Treatment rates appear to be declining, in part because only half of the patients know they are infected. If this disturbing trend continues, by 2030 less than 15% of liver-related deaths from HCV will be prevented by...


Latest antiviral therapy Reference Libraries

Antiviral Therapy
2012-05-21 08:53:18

Antiviral Therapy is a peer-reviewed academic journal published by International Medical Press (London, UK). The journal was established in 1996 by Douglas D. Richman (University of California, San Diego) and Joep M.A. Lange (University of Amsterdam, The Netherlands). The first two issues were published by MediTech Media Ltd. Issues were first published quarterly, and then bimonthly in 2003, and then eight times yearly in 2005. Antiviral Therapy is an official publication of the International...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »